KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Cost of Revenue: 2015-2024

Historic Cost of Revenue for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $1.5 billion.

  • Medpace Holdings' Cost of Revenue rose 27.08% to $463.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 11.58%. This contributed to the annual value of $1.5 billion for FY2024, which is 6.71% up from last year.
  • Latest data reveals that Medpace Holdings reported Cost of Revenue of $1.5 billion as of FY2024, which was up 6.71% from $1.4 billion recorded in FY2023.
  • Over the past 5 years, Medpace Holdings' Cost of Revenue peaked at $1.5 billion during FY2024, and registered a low of $647.2 million during FY2020.
  • Over the past 3 years, Medpace Holdings' median Cost of Revenue value was $1.4 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Data for Medpace Holdings' Cost of Revenue shows a peak YoY spiked of 32.48% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Medpace Holdings' Cost of Revenue stood at $647.2 million in 2020, then climbed by 25.81% to $814.2 million in 2021, then climbed by 26.20% to $1.0 billion in 2022, then spiked by 32.48% to $1.4 billion in 2023, then grew by 6.71% to $1.5 billion in 2024.